Online Exclusives
-
5 Tips to Make the Most of Contract Pharma's Conference & Tabletop Exhibition
With Contract Pharma’s annual contracting and outsourcing conference fast approaching, now’s the time to be making preparations to ensure you make the most of it. You’ve already invested in your tabletop exhibition space/delegate ti…Raman Sehgal, ramarketing 09.06.17
-
Cancer Trials in the New Age of Drug Development
Insights into the rapid pace of new drug approvals and the implications for pharma/biopharma companies08.21.17
-
cGMP Manufacture
Modernizing CMO Partnerships
Leveraging technology to facilitate seamless interactions between CMOs and sponsors08.21.17
-
Cell Therapy Industry Update: What to Expect Near-Term
Martin Lamb of TrakCel discusses the key players, challenges, and advances in the cell therapy industryKristin Brooks, Contract Pharma 07.10.17
-
Ready for BIO 2017?
Some tips on how to be a smart participant of BIO 2017 in San Diego next week.Ben Locwin, President, Healthcare Science Advisors 06.14.17
-
Will Immunotherapy Knock Out Cancer?
Innovative immunotherapy companies discuss with WuXi AppTec what’s next for this rapidly developing field ahead of BIO 2017.06.14.17
-
Why Data Drives Drug Insights After Market
Liaison Technologies’ Gary Palgon discusses how to make sense of pharmacovigilance data to reveal meaningful insightsKristin Brooks, Contract Pharma 05.09.17
-
Overcoming Preclinical Drug Development Hurdles
Aidan Synnott of Charles River Laboratories discusses the latest developments in oncology research modelsKristin Brooks, Contract Pharma 05.02.17
-
Regulatory Affairs
FDA’s Final Guidance: Steering Studies to Support Biosimilar Approval
IP attorney, Stacie Ropka, shares insight on this latest guidance and how it might impact the biosimilar marketKristin Brooks, Contract Pharma 04.20.17
-
Injectable Drug Delivery Trends
Graham Reynolds of West discusses the latest drug delivery strategies and trendsKristin Brooks, Contract Pharma 04.20.17
-
Inventing the MDI: A History in Modern Inhalation Therapy
3M’s Charlie Thiel offers insight into the pressurized metered-dose inhalerLynn Melling, Contributing Author 04.19.17
-
APIs | cGMP Manufacture
DCAT Week '17 Q&A: API Market Trends
Minzhang Chen of STA Pharmaceutical discusses the company’s business model, initiatives, and trends driving API developmentKristin Brooks, Contract Pharma 03.27.17
-
3D Printing Meets Pharma: Reward & Risk
Potential benefits are undeniable but the challenges and regulatory hurdles remain considerableKristin Brooks, Contract Pharma 03.03.17
-
Serialization | Supply Chain
Packaging Equipment Technology Preview
Today’s complex drug products present challenges; the latest equipment capabilities help overcome them02.15.17
-
The Good, the Bad, and the Donald
Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities01.31.17
-
Predictive Analytics and the Future of RBM
How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risksRajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS 01.23.17
-
APIs | cGMP Manufacture | Cytotoxics and High Potency Manufacturing
Patheon Furthers Expansion Strategy
Patrick Glaser of Patheon discusses expanded manufacturing capacity, capabilities, and future plansKristin Brooks, Contract Pharma 01.09.17
-
Trends Affecting the Generic Drugs Sector in 2017
Tighter capacity, consolidation, and drug pricing uncertainty among issues industry facesEd Price, President, PCI Synthesis 01.06.17
-
Drug Development in Today’s Changing Healthcare Market
John Corcoran of Trinity Partners discusses what’s next for the life sciences industryKristin Brooks, Contract Pharma 01.04.17
-
Aseptic Processing | cGMP Manufacture | Facilities | Fill/Finish | Regulatory Affairs | Serialization
